Newer, more direct kidney biomarkers of damage or stress, such as urinary insulin-like growth factor binding protein-7 (IGFBP-7) and tissue inhibitor of metalloproteinase-2 (TIMP-2) products, have shown promise in various contexts as tools for earlier detection of AKI. This evidence concerns the gene TIMP2 and acute kidney injury.